Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > LATEST
LATEST
-
ARCHIVE Korosho to Enhance Quality Surveillance System for Generics
September 24, 2007
-
ARCHIVE 24.7 Million Units of Influenza Vaccines to Be Supplied for Next Season
September 24, 2007
-
ARCHIVE GENERICS NEWS IN BRIEF
September 24, 2007
-
ARCHIVE European GL on Hypertension, Coronary Artery Disease Revised
September 24, 2007
-
ARCHIVE Mr Abe's Decision to Resign Sends Out Shockwave
September 24, 2007
-
ARCHIVE Disinfection in Boiling SDS Should Be Made Obligatory to Prevent Secondary Infection of CJD
September 24, 2007
-
ARCHIVE Korosho to Encourage Innovation While Optimizing Healthcare Expenditures: Mr Erikawa
September 24, 2007
-
ARCHIVE MEDICAL DEVICE NEWS IN BRIEF
September 24, 2007
-
ARCHIVE No Reduction in Technical Fees Considered: New Health Minister
September 17, 2007
-
ARCHIVE Med. Fee Curtailment Policy Caused Collapse of Med. Insurance System: 3 Social Insurance Unions
September 17, 2007
-
ARCHIVE Korosho to Shift Priority from Treatment of ADRs to Prevention
September 17, 2007
-
ARCHIVE TOPICS/JADEC, sanofi-aventis Hold HbA1c Awareness Promotion Campaign
September 17, 2007
-
ARCHIVE Use e-Details to Enhance QOV: Mr Takuma of CareNet
September 17, 2007
-
ARCHIVE Japan's First New-Type Influenza Vaccines Recommended for Approval
September 17, 2007
-
ARCHIVE SURVEY/Antirheumatic Drug Market Grew by 49% in 2006: Fuji Keizai Databook
September 17, 2007
-
ARCHIVE GENERICS NEWS IN BRIEF
September 17, 2007
-
ARCHIVE EFPIA Appreciates 20% Increase in Budget Request for Innovation
September 17, 2007
-
ARCHIVE Lundbeck, Takeda Tie Up to Develop Drugs for Mood and Anxiety Disorders
September 17, 2007
-
ARCHIVE CSL Behring Is Discriminated Against in Japan: President Mr Turner
September 17, 2007
-
ARCHIVE REGULATORY NEWS IN BRIEF
September 17, 2007
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…